Generic Medicine Info
Acute narrow-angle glaucoma, CNS depression or coma, myasthenia gravis, resp depression, coma, acute pulmonary insufficiency, sleep apnoea, severe hepatic impairment. Porphyria.
Special Precautions
Elderly or debilitated patients, pulmonary insufficiency, muscle weakness, organic brain changes, personality disorders, impaired liver or kidney function, history of alcohol or drug addiction due to risk of dependence. May precipitate suicide or aggressive behaviour.
Adverse Reactions
Drowsiness, sedation, muscle weakness, and ataxia. Less frequently, vertigo, headache, confusion, depression, slurred speech or dysarthria, changes in libido, tremor, visual disturbances, urinary retention or incontinence, GI upsets, changes in salivation, and amnesia. Rarely, jaundice, blood disorders, hypersensitivity reactions, raised liver enzyme values. Paradoxical excitation which may lead to hostility, aggression and disinhibition in some patients.
Drug Interactions
Enhanced sedation or resp and CV depression may occur if given with other drugs that have CNS depressant properties, cisapride.
CIMS Class
ATC Classification
M03BX07 - tetrazepam ; Belongs to the class of other centrally-acting muscle relaxants.
Disclaimer: This information is independently developed by CIMS based on tetrazepam from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in